NVCT
NVCT
US67080T1088
Nuvectis Pharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
27.574.000 19.847.000
38.9%
Operating Income -27.574.000 -19.847.000
38.9%
Pretax Income -26.442.000 -19.000.000
39.2%
Net Income Common Stockholders -28.871.000 -19.000.000
52.0%
-- --
--
-- --
--
ende